No products in the cart.
Rabbit Polyclonal Anti-CKR-5 antibody (STJ98700)
Supplier: St John’s Laboratory Ltd.
Recommended applications: WB, IHC-P, ELISA
Recommended dilution: WB 1:500-2000; IHC-P 1:50-300; ELISA 1:5000-20000
Recommended protocols: check protocols
Click or hover above images to see image description for Anti-CKR-5 antibody.
Check alternative names for the antibodyExpand
|AM4 7 antibody|C C chemokine receptor type 5 antibody|C C CKR 5 antibody|C-C chemokine receptor type 5 antibody|C-C CKR-5 antibody|C-C motif chemokine receptor 5 A159A antibody|CC Chemokine Receptor 5 antibody|CC Chemokine Receptor Type 5 antibody|CC CKR 5 antibody|CC-CKR-5 antibody|CCCKR 5 antibody|CCCKR5 antibody|CCR 5 antibody|CCR-5 antibody|CCR5 antibody|CCR5 chemokine (C C motif) receptor 5 antibody|CCR5_HUMAN antibody|CD 195 antibody|CD195 antibody|CD195 Antigen antibody|Chemokine C C motif receptor 5 antibody|Chemokine receptor CCR5 antibody|CHEMR13 antibody|CKR 5 antibody|CKR5 antibody|CMKBR 5 antibody|CMKBR5 antibody|FLJ78003 antibody|HIV 1 Fusion Coreceptor antibody|HIV-1 fusion coreceptor antibody|HIV1 fusion coreceptor antibody|IDDM22 antibody|MIP-1 alpha receptor antibody|Anti-CCR5 antibody (ab65850)
SCBT cat No: sc-6128|sc-8359|sc-17833|sc-55484|sc-13950|sc-6129|sc-8283|sc-32304|sc-57072|sc-53792|
|Catalogue No.|| |
Anti-CKR-5 antibody detects endogenous CKR-5.
Synthetic peptide from human protein at AA range: 151-200.
WB, IHC-P, ELISA
|Recommended dilution|| |
WB 1:500-2000; IHC-P 1:50-300; ELISA 1:5000-20000
|Molecular weight|| |
Anti-CKR-5 antibody was tube-contained in PBS, pH 7.4, containing 0.02% sodium azide as Preservative and 50% Glycerol.
Anti-CKR-5 antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen.
-20 Celsius degree. Avoid repeated freeze/thaw cycles.
|Alternative antibody names|| |
AM4 7 antibody, C C chemokine receptor type 5 antibody, C C CKR 5 antibody, C-C chemokine receptor type 5 antibody, C-C CKR-5 antibody, C-C motif chemokine receptor 5 A159A antibody, CC Chemokine Receptor 5 antibody, CC Chemokine Receptor Type 5 antibody, CC CKR 5 antibody, CC-CKR-5 antibody, CCCKR 5 antibody, CCCKR5 antibody, CCR 5 antibody, CCR-5 antibody, CCR5 antibody, CCR5 chemokine (C C motif) receptor 5 antibody, CCR5_HUMAN antibody, CD 195 antibody, CD195 antibody, CD195 Antigen antibody, Chemokine C C motif receptor 5 antibody, Chemokine receptor CCR5 antibody, CHEMR13 antibody, CKR 5 antibody, CKR5 antibody, CMKBR 5 antibody, CMKBR5 antibody, FLJ78003 antibody, HIV 1 Fusion Coreceptor antibody, HIV-1 fusion coreceptor antibody, HIV1 fusion coreceptor antibody, IDDM22 antibody, MIP-1 alpha receptor antibody
|Database links|| |
|Protein function|| |
Receptor for a number of inflammatory CC-chemokines including MIP-1-alpha, MIP-1-beta and RANTES and subsequently transduces a signal by increasing the intracellular calcium ion level. May play a role in the control of granulocytic lineage proliferation or differentiation. Acts as a coreceptor (CD4 being the primary receptor) for HIV-1 R5 isolates. .; (Microbial infection) Acts as a receptor for human immunodeficiency virus-1/HIV-1. .
|Protein tissue specificity|| |
Highly expressed in spleen, thymus, in the myeloid cell line THP-1, in the promyeloblastic cell line KG-1a and on CD4+ and CD8+ T-cells. Medium levels in peripheral blood leukocytes and in small intestine. Low levels in ovary and lung. .
|Involvement in disease|| |
Diabetes mellitus, insulin-dependent, 22 (IDDM22) [MIM:612522]: A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. . Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.
|Protein sequence and domain|| |
Belongs to the G-protein coupled receptor 1 family.
|Protein post-translational modifications|| |
Sulfated on at least 2 of the N-terminal tyrosines. Sulfation contributes to the efficiency of HIV-1 entry and is required for efficient binding of the chemokines, CCL3 and CCL4. .; O-glycosylated, but not N-glycosylated. Ser-6 appears to be the major site. Also sialylated glycans present which contribute to chemokine binding. Thr-16 and Ser-17 may also be glycosylated and, if so, with small moieties such as a T-antigen. .; Palmitoylation in the C-terminal is important for cell surface expression, and to a lesser extent, for HIV entry. .; Phosphorylation on serine residues in the C-terminal is stimulated by binding CC chemokines especially by APO-RANTES. .
|Protein cellular localization|| |
Cell membrane ; Multi-pass membrane protein .
AntibodyPlus can customize Anti-CKR-5 antibody according to your requirement, including bulk product size,etc. Please contact email@example.com. AntibodyPlus provide antibody trial sample for your own antibody validation and collects antibody reviews.
St John’s Laboratory Ltd.
|Product type|| |
There are no reviews for this product yet.
By submitting a review, get following benefits:
1. Receive $50 ABcoins as credit for each review.
2. First trial sample order will be fully refunded as credit.
3. Have a chance to win a $50 amazon gift card!
There is no extra validation for this product yet.
Check other extra validated antibodies below: